ADMA
ADMA Biologics, Inc.#9 · 2024EPBYearly return
+277%
Peak return
+420%
Max drawdown
-28%
ADR (20 days)
+3.9%
Base
22 days / -15.4%
Prior run
+60%
Breakout volume
5.4x
Pivot
$6.97
Catalyst Earnings/Guidance2024-05-09Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Materials · Materials/Commodities
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare ADMA with the current market directly.